190 related articles for article (PubMed ID: 38055114)
41. The hemagglutinin-neuraminidase glycoproteins of human parainfluenza virus type 1 and Sendai virus have high structure-function similarity with limited antigenic cross-reactivity.
Gorman WL; Gill DS; Scroggs RA; Portner A
Virology; 1990 Mar; 175(1):211-21. PubMed ID: 1689918
[TBL] [Abstract][Full Text] [Related]
42. Computational formulation and immune dynamics of a multi-peptide vaccine candidate against Crimean-Congo hemorrhagic fever virus.
Khan MSA; Nain Z; Syed SB; Abdulla F; Moni MA; Sheam MM; Karim MM; Adhikari UK
Mol Cell Probes; 2021 Feb; 55():101693. PubMed ID: 33388416
[TBL] [Abstract][Full Text] [Related]
43. Characterization of naturally occurring parainfluenza virus type 2 (hPIV-2) variants.
Terrier O; Cartet G; Ferraris O; Morfin F; Thouvenot D; Hong SS; Lina B
J Clin Virol; 2008 Sep; 43(1):86-92. PubMed ID: 18579437
[TBL] [Abstract][Full Text] [Related]
44. Immunoinformatics approach for designing a universal multiepitope vaccine against Chandipura Virus.
Banik A; Sinha S; Ahmed SR; Chowdhury MMH; Mukta S; Ahmed N; Rani NA
Microb Pathog; 2022 Jan; 162():105358. PubMed ID: 34902539
[TBL] [Abstract][Full Text] [Related]
45. An immunoinformatics and structural vaccinology study to design a multi-epitope vaccine against Staphylococcus aureus infection.
Chatterjee R; Mahapatra SR; Dey J; Raj Takur K; Raina V; Misra N; Suar M
J Mol Recognit; 2023 Apr; 36(4):e3007. PubMed ID: 36700877
[TBL] [Abstract][Full Text] [Related]
46. Computational vaccinology guided design of multi-epitopes subunit vaccine designing against Hantaan virus and its validation through immune simulations.
Ghafoor D; Kousar A; Ahmed W; Khan S; Ullah Z; Ullah N; Khan S; Ahmed S; Khan Z; Riaz R
Infect Genet Evol; 2021 Sep; 93():104950. PubMed ID: 34089911
[TBL] [Abstract][Full Text] [Related]
47. Human parainfluenza virus infection in severe acute respiratory infection cases in Beijing, 2014-2016: A molecular epidemiological study.
Pan Y; Zhang Y; Shi W; Peng X; Cui S; Zhang D; Lu G; Liu Y; Wu S; Yang P; Wang Q
Influenza Other Respir Viruses; 2017 Nov; 11(6):564-568. PubMed ID: 29054112
[TBL] [Abstract][Full Text] [Related]
48. Beyond the state of the art of reverse vaccinology: predicting vaccine efficacy with the universal immune system simulator for influenza.
Russo G; Crispino E; Maleki A; Di Salvatore V; Stanco F; Pappalardo F
BMC Bioinformatics; 2023 Jun; 24(1):231. PubMed ID: 37271819
[TBL] [Abstract][Full Text] [Related]
49. Immunoinformatics-Aided Design of a Peptide Based Multiepitope Vaccine Targeting Glycoproteins and Membrane Proteins against Monkeypox Virus.
Akhtar N; Kaushik V; Grewal RK; Wani AK; Suwattanasophon C; Choowongkomon K; Oliva R; Shaikh AR; Cavallo L; Chawla M
Viruses; 2022 Oct; 14(11):. PubMed ID: 36366472
[TBL] [Abstract][Full Text] [Related]
50. Vaccinomics-aided next-generation novel multi-epitope-based vaccine engineering against multidrug resistant Shigella Sonnei: Immunoinformatics and chemoinformatics approaches.
Aiman S; Ahmad A; Khan A; Ali Y; Malik A; Alkholief M; Akhtar S; Khan RS; Li C; Jalil F; Ali Y
PLoS One; 2023; 18(11):e0289773. PubMed ID: 37992050
[TBL] [Abstract][Full Text] [Related]
51. Design of a multi-epitope peptide vaccine candidate against chandipura virus: an immuno-informatics study.
Pavitrakar DV; Atre NM; Tripathy AS; Shil P
J Biomol Struct Dyn; 2022 Feb; 40(2):648-659. PubMed ID: 32897148
[TBL] [Abstract][Full Text] [Related]
52. A multiepitope vaccine candidate against infectious bursal disease virus using immunoinformatics-based reverse vaccinology approach.
Gul I; Hassan A; Muneeb JM; Akram T; Haq E; Shah RA; Ganai NA; Ahmad SM; Chikan NA; Shabir N
Front Vet Sci; 2022; 9():1116400. PubMed ID: 36713875
[TBL] [Abstract][Full Text] [Related]
53. Reverse vaccinology approach to design a novel multi-epitope subunit vaccine against avian influenza A (H7N9) virus.
Hasan M; Ghosh PP; Azim KF; Mukta S; Abir RA; Nahar J; Hasan Khan MM
Microb Pathog; 2019 May; 130():19-37. PubMed ID: 30822457
[TBL] [Abstract][Full Text] [Related]
54. Exploring
Dey J; Mahapatra SR; Lata S; Patro S; Misra N; Suar M
Expert Rev Vaccines; 2022 Apr; 21(4):569-587. PubMed ID: 34932430
[TBL] [Abstract][Full Text] [Related]
55. In silico design and evaluation of a novel mRNA vaccine against BK virus: a reverse vaccinology approach.
Mohammadi Y; Nezafat N; Negahdaripour M; Eskandari S; Zamani M
Immunol Res; 2023 Jun; 71(3):422-441. PubMed ID: 36580228
[TBL] [Abstract][Full Text] [Related]
56. Immunoinformatic approach for the construction of multi-epitopes vaccine against omicron COVID-19 variant.
Khan K; Khan SA; Jalal K; Ul-Haq Z; Uddin R
Virology; 2022 Jul; 572():28-43. PubMed ID: 35576833
[TBL] [Abstract][Full Text] [Related]
57. Exploiting the reverse vaccinology approach to design novel subunit vaccines against Ebola virus.
Ullah MA; Sarkar B; Islam SS
Immunobiology; 2020 May; 225(3):151949. PubMed ID: 32444135
[TBL] [Abstract][Full Text] [Related]
58. Antigenic diversity of human parainfluenza virus type 1 isolates and their immunological relationship with Sendai virus revealed by using monoclonal antibodies.
Komada H; Kusagawa S; Orvell C; Tsurudome M; Nishio M; Bando H; Kawano M; Matsumura H; Norrby E; Ito Y
J Gen Virol; 1992 Apr; 73 ( Pt 4)():875-84. PubMed ID: 1378879
[TBL] [Abstract][Full Text] [Related]
59. In silico screening of antigenic B-cell derived T-cell epitopes and designing of a multi-epitope peptide vaccine for Acinetobacter nosocomialis.
Sajjad R; Ahmad S; Azam SS
J Mol Graph Model; 2020 Jan; 94():107477. PubMed ID: 31654980
[TBL] [Abstract][Full Text] [Related]
60. Human parainfluenza virus circulation, United States, 2011-2019.
DeGroote NP; Haynes AK; Taylor C; Killerby ME; Dahl RM; Mustaquim D; Gerber SI; Watson JT
J Clin Virol; 2020 Mar; 124():104261. PubMed ID: 31954277
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
